Towards an individualised approach to pain management in inflammatory arthritis

Therapeutic Advances in Musculoskeletal Disease · Published 2026-06-01 · DOI 10.1177/1759720x261452012

Free full text

Authors (5)

Zoe Rutter-Locher, Franziska Denk, Leonie S. Taams, Bruce W. Kirkham, Kirsty Bannister

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Rutter-Locher, Z., Denk, F., Taams, L., et al. (2026). Towards an individualised approach to pain management in inflammatory arthritis. Therapeutic Advances in Musculoskeletal Disease. https://doi.org/10.1177/1759720x261452012

Related articles

• A transfer learning–based approach for automated bone fracture classification in X-ray imaging · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• High-dose folic acid supplement is associated with increased cardiovascular risk in rheumatoid arthritis patients on methotrexate · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Temporal trends and future projections of hand osteoarthritis burden in China from 1990 to 2021 · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Patient and public involvement in musculoskeletal pain research: using mutual learning to improve research quality · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Cardiometabolic disease and risk of total knee arthroplasty among patients with knee osteoarthritis receiving intra-articular hyaluronic acid: a real-world cohort study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Early identification of difficult-to-manage axial spondyloarthritis using machine-learning decision trees · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Serum interleukin-8 levels relate to disease activity in patients with rheumatoid arthritis · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal
• Associations of blood cell indices with the severity of rheumatoid arthritis: a retrospective case–control and machine learning modeling study · Therapeutic Advances in Musculoskeletal Disease · 2026 · Same journal